Raab & Moskowitz Asset Management’s AstraZeneca AZN Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-230	Closed	-$22K	–	161
2019 Q4	$22K	Buy	+230	New	+$21.7K	0.01%	329
2018 Q4	–	Sell	-318	Closed	-$25K	–	181
2018 Q3	$25K	Buy	+318	New	+$24.1K	0.01%	321
2015 Q1	–	Sell	-505	Closed	-$36K	–	132
2014 Q4	$36K	Buy	+505	New	+$36.2K	0.02%	220

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raab & Moskowitz Asset Management's AZN Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of AstraZeneca (AZN) in Q1 2020, closing a stake of 230 shares — an estimated $22K sold.

Raab & Moskowitz Asset Management first reported a position in AZN in Q4 2014 and held it in 3 quarters. The position peaked at $36K in Q4 2014. 603 funds tracked by Wall St. Rank hold AZN as of Q1 2020.

Raab & Moskowitz Asset Management reported no remaining AstraZeneca position as of Q1 2020 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 230 AstraZeneca shares in Q1 2020, an estimated $22K.
Raab & Moskowitz Asset Management first reported a position in AstraZeneca in Q4 2014 and held it in 3 quarters.
Raab & Moskowitz Asset Management's AstraZeneca position peaked at $36K in Q4 2014.
603 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.